317 related articles for article (PubMed ID: 18806522)
1. Prevalence of use of cardiovascular drugs in 499 patients with suspected coronary artery disease at time of hospitalization for coronary angiography and in 357 patients with obstructive coronary artery disease documented by coronary angiography.
Mazar M; Schair B; Aronow WS; Khalique O; Lehrman SG
Am J Ther; 2008; 15(5):458-60. PubMed ID: 18806522
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
Banasiak W; Wilkins A; Pociupany R; Ponikowski P
Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
Mostaza JM; Lahoz C; Martín-Jadraque R; Sanmartín MA; Vicente I; Tranche S; Taboada M; Mantilla T; Monteiro B; Sanchez-Zamorano MA;
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):34-8. PubMed ID: 19237995
[TBL] [Abstract][Full Text] [Related]
5. Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease.
Sanal S; Aronow WS
J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1046-8. PubMed ID: 14630888
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
Joseph J; Koka M; Aronow WS
J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706
[TBL] [Abstract][Full Text] [Related]
7. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program.
Lewis WR; Ellrodt AG; Peterson E; Hernandez AF; LaBresh KA; Cannon CP; Pan W; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):633-41. PubMed ID: 20031902
[TBL] [Abstract][Full Text] [Related]
8. Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic.
Nayak D; Aronow WS
Cardiol Rev; 2005; 13(2):95-7. PubMed ID: 15705260
[TBL] [Abstract][Full Text] [Related]
9. [Secondary prevention in chronic coronary heart disease].
Hunziker P; Bertel O
Schweiz Med Wochenschr; 1997 Feb; 127(7):254-60. PubMed ID: 9157530
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
Granmyr J; Ball P; Curran S; Wang L
Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
Barski L; Porath A; Novack V; Jotkowitz A
Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
Imaizumi S; Miura S; Nishikawa H; Iwata A; Zhang B; Kawamura A; Tsuchiya Y; Kumagai K; Matsuo K; Saku K
Hypertens Res; 2006 Mar; 29(3):135-41. PubMed ID: 16755148
[TBL] [Abstract][Full Text] [Related]
14. How should we manage heart failure developing in patients already treated with angiotensin-converting enzyme inhibitors and beta-blockers for hypertension, diabetes or coronary disease?
Gustafsson F; Segura J; Ruilope LM
J Hypertens; 2010 Aug; 28(8):1595-8. PubMed ID: 20613629
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
[TBL] [Abstract][Full Text] [Related]
16. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?
Tomaszuk-Kazberuk A; Kozuch M; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Musial WJ
Ren Fail; 2013; 35(2):235-42. PubMed ID: 23176538
[TBL] [Abstract][Full Text] [Related]
19. [Secondary prevention in patients before and after percutaneous transluminal coronary angioplasty: 5-year follow-up].
Muntwyler J; Maschio Andrist M; Amann FW
Schweiz Med Wochenschr; 1997 Apr; 127(14):573-8. PubMed ID: 9198883
[TBL] [Abstract][Full Text] [Related]
20. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
